Felodipin-Natrapharm Special Precautions

Felodipine should be used with caution in patients with conduction disorders, heart failure, tachycardia and hemodynamically relevant aortic and/or mitral valve stenosis; mild to moderate hepatic impairment, as the antihypertensive effect may be enhanced; if treatment with felodipine is discontinued abruptly, a hypertensive crisis may occur in individual cases.
Effects on the Ability to Drive or Operate Machinery: Treatment of essential hypertension with felodipine requires regular medical monitoring. Individually, different reactions may alter alertness to such an extent that the ability to actively participate in road traffic, operate machines or work without a firm support is impaired. This applies especially at the start of therapy, when increasing the dose, switching medications or using alcohol at the same time.
Use in lactation: Felodipine is excreted in breast milk. If the breastfeeding mother is taking therapeutic doses of felodipine, a fully breastfed infant absorbs only a very low dose of the active substance with the breast milk. There exists no experience concerning the risk for the infant.
Use in children: Felodipine should not be used in children because safety has not been established.